FDA Approves New Pancreatic Cancer Drug
See how ABC are framing this — we run every side, so you decide. News for humans, not bots: serious, civil discussion among real people, with the context and facts you need. Don't just watch: be on the air with your own video takes, polls and predictions.
EVERY NETWORK'S FRAMING
Watch the moment
Add your voice
This storyWhat type of cancer did the FDA approves a new drug to treat?
What cancer game-changer drug was approved by the FDA in 2023?
Pancreatic cancer has a 5-year survival rate of only about 13%
FDA approval and a CDC recommendation are two separate steps!
The FDA rules a treatment safe & effective after clinical trials. Then the CDC's ACIP separately votes on who should receive it. And '95% efficacy' means 95% fewer cases vs. placebo — not blanket protection.